Larimar Non Current Assets Total from 2010 to 2025

LRMR Stock  USD 2.40  0.15  6.67%   
Larimar Therapeutics Non Current Assets Total yearly trend continues to be relatively stable with very little volatility. Non Current Assets Total are likely to drop to about 3.3 M. Non Current Assets Total is the total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets. View All Fundamentals
 
Non Current Assets Total  
First Reported
2014-06-30
Previous Quarter
5.8 M
Current Value
4.9 M
Quarterly Volatility
3.8 M
 
Yuan Drop
 
Covid
Check Larimar Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Larimar Therapeutics' main balance sheet or income statement drivers, such as Interest Expense of 472.6 K, Selling General Administrative of 12.9 M or Other Operating Expenses of 38.2 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.45. Larimar financial statements analysis is a perfect complement when working with Larimar Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Larimar Therapeutics Correlation against competitors.
To learn how to invest in Larimar Stock, please use our How to Invest in Larimar Therapeutics guide.

Latest Larimar Therapeutics' Non Current Assets Total Growth Pattern

Below is the plot of the Non Current Assets Total of Larimar Therapeutics over the last few years. It is the total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets. Larimar Therapeutics' Non Current Assets Total historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Larimar Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Non Current Assets Total10 Years Trend
Slightly volatile
   Non Current Assets Total   
       Timeline  

Larimar Non Current Assets Total Regression Statistics

Arithmetic Mean2,352,506
Geometric Mean1,123,599
Coefficient Of Variation110.71
Mean Deviation2,341,758
Median722,000
Standard Deviation2,604,488
Sample Variance6.8T
Range6.4M
R-Value0.76
Mean Square Error3.1T
R-Squared0.58
Significance0.0006
Slope416,490
Total Sum of Squares101.8T

Larimar Non Current Assets Total History

20253.3 M
20244.9 M
20235.8 M
20225.7 M
20216.5 M
20206.7 M
2019451 K

About Larimar Therapeutics Financial Statements

Larimar Therapeutics shareholders use historical fundamental indicators, such as Non Current Assets Total, to determine how well the company is positioned to perform in the future. Although Larimar Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Larimar Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Larimar Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Non Current Assets Total4.9 M3.3 M

Pair Trading with Larimar Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Larimar Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Larimar Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving together with Larimar Stock

  0.83CDIOW Cardio DiagnosticsPairCorr
  0.7ELVN Enliven TherapeuticsPairCorr

Moving against Larimar Stock

  0.82LUCD Lucid DiagnosticsPairCorr
  0.75WM Waste ManagementPairCorr
  0.61GE GE AerospacePairCorr
  0.43PLX Protalix BiotherapeuticsPairCorr
  0.34PG Procter Gamble Sell-off TrendPairCorr
The ability to find closely correlated positions to Larimar Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Larimar Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Larimar Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Larimar Therapeutics to buy it.
The correlation of Larimar Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Larimar Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Larimar Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Larimar Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Larimar Stock Analysis

When running Larimar Therapeutics' price analysis, check to measure Larimar Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Larimar Therapeutics is operating at the current time. Most of Larimar Therapeutics' value examination focuses on studying past and present price action to predict the probability of Larimar Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Larimar Therapeutics' price. Additionally, you may evaluate how the addition of Larimar Therapeutics to your portfolios can decrease your overall portfolio volatility.